Teladoc Inc. (NYSE:TDOC) Receives $22.86 Average Price Target from Analysts
Teladoc Inc. (NYSE:TDOC) has earned an average recommendation of “Buy” from the thirteen analysts that are currently covering the stock. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and eleven have given a buy rating to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $22.86.
A number of research analysts have issued reports on TDOC shares. FBR & Co reduced their price target on Teladoc from $36.00 to $34.00 and set an “outperform” rating for the company in a research report on Wednesday, July 20th. Stifel Nicolaus initiated coverage on Teladoc in a report on Wednesday, June 1st. They issued a “hold” rating for the company. Piper Jaffray Cos. restated an “overweight” rating and issued a $22.00 price objective (up previously from $20.00) on shares of Teladoc in a report on Monday, July 11th. Zacks Investment Research upgraded Teladoc from a “hold” rating to a “buy” rating and set a $20.00 price objective for the company in a report on Monday, July 25th. Finally, Oppenheimer Holdings Inc. restated an “outperform” rating and issued a $24.00 price objective (down previously from $25.00) on shares of Teladoc in a report on Friday, August 5th.
In related news, CEO Jason N. Gorevic sold 5,000 shares of the company’s stock in a transaction on Friday, July 15th. The stock was sold at an average price of $15.45, for a total transaction of $77,250.00. Following the transaction, the chief executive officer now directly owns 932,258 shares of the company’s stock, valued at $14,403,386.10. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jason N. Gorevic sold 40,000 shares of the company’s stock in a transaction on Tuesday, August 16th. The shares were sold at an average price of $17.92, for a total value of $716,800.00. Following the transaction, the chief executive officer now directly owns 967,258 shares in the company, valued at $17,333,263.36. The disclosure for this sale can be found here. Corporate insiders own 5.94% of the company’s stock.
A number of hedge funds and other institutional investors have recently bought and sold shares of TDOC. Macquarie Group Ltd. acquired a new position in Teladoc during the second quarter valued at $931,000. Nomura Holdings Inc. purchased a new position in shares of Teladoc during the second quarter valued at $241,000. Schwab Charles Investment Management Inc. raised its position in shares of Teladoc by 100.2% in the second quarter. Schwab Charles Investment Management Inc. now owns 42,830 shares of the company’s stock valued at $687,000 after buying an additional 21,436 shares during the last quarter. Elk Creek Partners LLC raised its position in shares of Teladoc by 1.6% in the second quarter. Elk Creek Partners LLC now owns 653,066 shares of the company’s stock valued at $10,462,000 after buying an additional 10,513 shares during the last quarter. Finally, Metropolitan Life Insurance Co. NY purchased a new position in shares of Teladoc during the second quarter valued at $268,000. 40.45% of the stock is currently owned by hedge funds and other institutional investors.
Teladoc (NYSE:TDOC) opened at 18.11 on Monday. The stock’s 50 day moving average is $18.20 and its 200 day moving average is $14.15. Teladoc has a 12 month low of $9.08 and a 12 month high of $23.00. The firm’s market cap is $827.72 million.
Teladoc (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, August 3rd. The company reported ($0.38) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.39) by $0.01. Teladoc had a negative return on equity of 33.97% and a negative net margin of 60.88%. The company earned $26.50 million during the quarter, compared to analyst estimates of $28.20 million. During the same quarter in the previous year, the firm posted ($0.46) EPS. The firm’s quarterly revenue was up 44.9% on a year-over-year basis. On average, equities analysts forecast that Teladoc will post ($1.45) earnings per share for the current year.
Teladoc, Inc, together with its subsidiaries, is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company operates through health services segment. Its solution connects its Members, with its over 3,000 board-certified physicians and behavioral health professionals who treat a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.
Receive News & Stock Ratings for Teladoc Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc. and related stocks with our FREE daily email newsletter.